Empery Asset Management, LP - TC BIOPHARM HOLDINGS PLC ownership

Back to all holdings Add to watchlist

TC BIOPHARM HOLDINGS PLC's ticker is and the CUSIP is 87807D111. A total of 8 filers reported holding TC BIOPHARM HOLDINGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Links
Filings
Quarter-by-quarter ownership
Empery Asset Management, LP ownership history of TC BIOPHARM HOLDINGS PLC
ValueSharesWeighting
Q3 2022$653,000
+14.4%
2,823,5280.0%3.89%
+25.7%
Q2 2022$571,000
-58.7%
2,823,5280.0%3.09%
-52.5%
Q1 2022$1,384,000–2,823,528–6.50%–
 Download
Other shareholders
TC BIOPHARM HOLDINGS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Nantahala Capital Management 235,294$23,5060.00%
Altium Capital Management LP 18,823$1,8800.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 14,174$1,4100.00%
ARMISTICE CAPITAL, LLC 37,648$3,7610.00%
UBS Group AG 200$200.00%
View complete list of TC BIOPHARM HOLDINGS PLC shareholders